Adbry recalls
Adbry products have been recalled 1 time, most recently on 4 Mar 2026. The recalling company is usually LEO Pharma. The most common reason is particulate matter.
Total recalls1since 2026
Last 12 months1reported
Class I00% of total
Ongoing1latest 4 Mar 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why adbry is recalled
Companies
Product types
By year
Ongoing adbry recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Adbry, (tralokinumab-ldrm) injection, 300 mg recalled by Leo PharmaAdbry | LEO Pharma | Particulate Matter | Nationwide |
All adbry recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Adbry, (tralokinumab-ldrm) injection, 300 mg recalled by Leo PharmaAdbry | LEO Pharma | Particulate Matter | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.